Literature DB >> 1985733

Combined surgical resection and iridium 192 implantation for locally advanced and recurrent desmoid tumors.

M J Zelefsky1, L B Harrison, M H Shiu, J G Armstrong, S I Hajdu, M F Brennan.   

Abstract

Thirty-eight histologically confirmed desmoid tumors were treated with conservative surgical resection and interstitial iridium 192. Patients included in this series constituted a poor prognostic group. Seventy five percent (75%) had previous recurrences of their disease and 50% had tumors 8 cm or greater in size. In addition, 16% of the patients had gross residual disease after surgical excision and 79% had positive or close margins of resection. With a median follow-up of 5.5 years, the 5-year actuarial in-field local control rate was 75% and the overall local control rate was 66%. Four of the 12 local recurrences developed at the periphery of the implant volume and four patients failed at least 3 cm or more beyond the treated volume. After salvage therapy, the 5-year actuarial local control rate was 95%. Two patients required amputation for recurrent disease. Thirty of 34 patients remain free of disease with an excellent functional result achieved. The authors conclude that surgical resection and postoperative interstitial iridium 192 is effective therapy for patients with desmoid tumors. Despite the fact that most patients in this series had bulky, recurrent tumors, excellent long-term local control and limb function were achieved.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985733     DOI: 10.1002/1097-0142(19910115)67:2<380::aid-cncr2820670211>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Desmoid tumor of the chest wall following chest surgery: report of a case.

Authors:  J Shimizu; Y Kawaura; Y Tatsuzawa; K Maeda; M Oda; A Kawashima
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation.

Authors:  N A Janjan; A W Yasko; G P Reece; M J Miller; J A Murray; M I Ross; M M Romsdahl; M J Oswald; T G Ochran; R E Pollock
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

3.  Current trends in the management of extra-abdominal desmoid tumours.

Authors:  Panayiotis J Papagelopoulos; Andreas F Mavrogenis; Evanthia A Mitsiokapa; Kleo Th Papaparaskeva; Evanthia C Galanis; Panayotis N Soucacos
Journal:  World J Surg Oncol       Date:  2006-04-03       Impact factor: 2.754

4.  The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network.

Authors:  Brigitta G Baumert; Martin O Spahr; Arthur Von Hochstetter; Sylvie Beauvois; Christine Landmann; Katrin Fridrich; Salvador Villà; Michael J Kirschner; Guy Storme; Peter Thum; Hans K Streuli; Norbert Lombriser; Robert Maurer; Gerhard Ries; Ernst-Arnold Bleher; Alfred Willi; Juerg Allemann; Ulrich Buehler; Hugo Blessing; Urs M Luetolf; J Bernard Davis; Burkhardt Seifert; Manfred Infanger
Journal:  Radiat Oncol       Date:  2007-03-07       Impact factor: 3.481

5.  Adjuvant Radiation Therapy of Retroperitoneal Sarcoma: The Role of Intraoperative Radiotherapy (IORT).

Authors:  K S Hu; L C Harrison
Journal:  Sarcoma       Date:  2000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.